BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17604140)

  • 1. A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer.
    Ash D; Bottomley D; Al-Qaisieh B; Carey B; Gould K; Henry A
    Radiother Oncol; 2007 Aug; 84(2):135-9. PubMed ID: 17604140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
    Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
    J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study.
    Hashine K; Yuasa A; Shinomori K; Ninomiya I; Kataoka M; Yamashita N
    Int J Urol; 2011 Dec; 18(12):813-9. PubMed ID: 21995507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
    Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
    Miller NL; Bissonette EA; Bahnson R; Wilson J; Theodorescu D
    Cancer; 2003 Mar; 97(5):1203-10. PubMed ID: 12599226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Feigenberg SJ; Lee WR; Desilvio ML; Winter K; Pisansky TM; Bruner DW; Lawton C; Morton G; Baikadi M; Sandler H
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):956-64. PubMed ID: 15989995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
    Roeloffzen EM; Lips IM; van Gellekom MP; van Roermund J; Frank SJ; Battermann JJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1054-60. PubMed ID: 20097486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds.
    Bottomley D; Ash D; Al-Qaisieh B; Carey B; Joseph J; St Clair S; Gould K
    Radiother Oncol; 2007 Jan; 82(1):46-9. PubMed ID: 17161481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results.
    Duchesne GM; Williams SG; Das R; Tai KH
    Radiother Oncol; 2007 Aug; 84(2):128-34. PubMed ID: 17561293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
    Keyes M; Miller S; Moravan V; Pickles T; McKenzie M; Pai H; Liu M; Kwan W; Agranovich A; Spadinger I; Lapointe V; Halperin R; Morris WJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1023-32. PubMed ID: 19111402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
    Vordermark D; Noe M; Markert K; Wulf J; Müller G; Bratengeier K; Beckmann G; Baier F; Guckenberger M; Schiefelbein F; Schön G; Flentje M; Baier K
    Radiother Oncol; 2009 May; 91(2):217-24. PubMed ID: 19136175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term rectal function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
    Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.
    Litwin MS; Sadetsky N; Pasta DJ; Lubeck DP
    J Urol; 2004 Aug; 172(2):515-9. PubMed ID: 15247718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
    BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.